The 18th Forum Biotech Patenting will take place on March 17th and 18th, 2010 in the Hotel Vier Jahreszeiten Kempinski of Munich.

"Latest developments and newest strategies for maximising protection and optimising the value of your Biotechnology Portfolio".

Established among biotech practitioners as the market leading event, C5’s Biotech Patenting Conference is the one place biotech patent practitioners come to learn and discuss the most recent and vital changes facing the industry today.

The 18th C5 Forum on Biotech Patenting brings together a panel of experts comprising regulators, in-house counsel and their advisors, to provide you with an essential briefing and update on the state of biotech patenting today. By attending, you will:

• Follow a lively debate on the latest strategies for adapting your patent practice to EPO rule changes
• Hear directly from the EPO on patentability, their latest requirements and key policy changes
• Find out about disclosure requirements for gene patents: from T 1329/04 to Eli Lily vs HGS – what is patentable?
• Identify what the Enlarged Board’s Decision on Second Medical Use Claims means for your claims drafting
• Maximise your patent protection with a critical review of recent developments and decisions on the availability of SPCs
• Improve your claims drafting to meet heightened patentability requirements for antibodies
• Master the ethical minefield: defining “embryonic stem cells” within Europe’s borders

More informations, program, registration, click here